AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27229348
Drug: Melatonin 10
RxNorm normalized name: melatonin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 10 mg/day
Trial: 20499349
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of zoledronate
Trial: 11011338
Drug: Low-dose warfarin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose warfarin (1 to 4 mg/d)
Trial: 11011338
Drug: Antioxidant vitamin
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamin treatment
Trial: 8803378
Drug: Sustained-release morphine
RxNorm normalized name: morphine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release morphine (SRM) administered at a 12‐hr interval
Trial: 8803378
Drug: Sustained-release morphine
RxNorm normalized name: morphine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release morphine (SRM)
Trial: 1454315
Drug: Timolol 0.25%
RxNorm normalized name: Timolol 0.25% Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol 0.25% or 0.5% twice daily
Trial: 1454315
Drug: Pilocarpine 2%
RxNorm normalized name: PILOCARPINE 2% SOLN,OPH
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pilocarpine 2% or 4% four times daily
Trial: 6609521
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate (Abboticin) in standard dosage for the last 10 days before surgery
Trial: 28506134
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg BIW
Trial: 28506134
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg QW
Trial: 24429167
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of MTX and etanercept
Trial: 20651609
Drug: Heterozygous (GA)
RxNorm normalized name: Heterologous human adult liver derived progenitor cells
DrugBank: Heterologous human adult liver derived progenitor cells (DB17695)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heterozygous (GA) for the FPGS IVS1 (28) G>A polymorphism
Trial: 17365851
Drug: Garlic oil
RxNorm normalized name: Garlic Oil
DrugBank: Garlic oil (DB15989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic oil (9.9 g dose)
Trial: 16305652
Drug: rHuEpo administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rHuEpo administration for 6 months
Trial: 11889776
Drug: Droperidol 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 5.0 mg
Trial: 11889776
Drug: Epidural administration
RxNorm normalized name: epidural administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural administration of 0.25% bupivacaine 40 ml and buprenorphine 0.4 mg
Trial: 7616870
Drug: Combined norethisterone
RxNorm normalized name: ethisterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined norethisterone acetate (NETA)/oestradiol (E2)‐TTS, delivering 0.25 mg NETA and 50 micrograms E2 per day, continuously for 12 calendar months
Trial: 1967425
Drug: Soluble prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Soluble prednisolone (20 mg twice daily on days 1-10 of the female partner's menstrual cycle, followed by 5 mg on days 11 and 12)
Trial: 326101
Drug: Flunisolide aerosol
RxNorm normalized name: Flunisolide
DrugBank: Flunisolide acetate (DB14662)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flunisolide aerosol administered every 12 hours for eight weeks
Trial: 28363933
Drug: Melatonin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (2 mg and 0.5 mg)
Trial: 22835606
Drug: Specific oral
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific oral tolerance induction (SOTI) with powdered pasteurised egg, starting with 1mg and increasing weekly to 10g over an average duration of 10 weeks.
Trial: 19925284
Drug: Spironolactone 25
RxNorm normalized name: spironolactone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25 mg for six months (Group 1)
Trial: 10474065
Drug: Org 4428
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 4428 (25 mg)
Trial: 10474065
Drug: Org 4428
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 4428 (100 mg)
Trial: 8683634
Drug: Combined adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined adjuvant chemotherapy and radiation therapy
Trial: 8683634
Drug: Adjuvant radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant radiation therapy alone
Trial: 6822108
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) 5 to 30 mg
Trial: 29669001
Drug: Pneumococcal Conjugate
RxNorm normalized name: pneumococcal conjugate PCV 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal Conjugate Vaccine 10
Trial: 29669001
Drug: Pneumococcal Conjugate
RxNorm normalized name: pneumococcal conjugate PCV 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal Conjugate Vaccine 13
Trial: 27033905
Drug: Dexketoprofen 1
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen 1 mg/kg IV (group DK)
Trial: 27033905
Drug: Methadone 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 0.2 mg/kg IV (group M)
Trial: 14720266
Drug: TBC1269 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBC1269 (30 mg/kg)
Trial: 11223496
Drug: ProBAN sublingual
RxNorm normalized name: Probanthine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ProBAN sublingual tablets and nicotine gum
Trial: 11223496
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets and nicotine gum
Trial: 1088099
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of doxycycline on admission and 100 mg on the second day
Trial: 1088099
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of doxycycline on admission only
Trial: 1088099
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of doxycycline on admission only
Trial: 1088099
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of tetracycline every 6 h for 48 h
Trial: 31925529
Drug: 23-month ticagrelor
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 23-month ticagrelor monotherapy after 1-month ticagrelor and aspirin dual anti-platelet therapy (DAPT)
Trial: 31925529
Drug: 12-month DAPT
RxNorm normalized name: DAPT
DrugBank: Diaminopropanol tetraacetic acid (DB12362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month DAPT followed by 12-month aspirin
Trial: 28685712
Drug: Shensong Yangxin
RxNorm normalized name: CAMPHOR (SYNTHETIC) 4.28 mg in 100 mg / MENTHOL 2.84 mg in 100 mg / METHYL SALICYLATE 1.4 mg in 100 mg TRANSDERMAL PLASTER [Shennong Analgesic Plaster]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shensong Yangxin capsules (SSYX)
Trial: 23307069
Drug: 32 mg
RxNorm normalized name: caffeine 32 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 mg of CBD administered post-extinction
Trial: 23307069
Drug: 32 mg
RxNorm normalized name: caffeine 32 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 mg of CBD administered before extinction
Trial: 19165663
Drug: 750 IU
RxNorm normalized name: Pegaspargase 750 IU/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 IU of hCG every three days during endometrial preparation with estradiol
Trial: 16500921
Drug: Propranolol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol infusion with mixed liquid meal (700 kcal)
Trial: 14985214
Drug: Enteral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteral glutamine (0.6 g.kg(‐1).d(‐1))
Trial: 9420391
Drug: 5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml/kg plain water orally 3 hours before surgery
Trial: 9420391
Drug: 5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml/kg plain water and 2 mg/kg of ranitidine orally 3 hours before surgery
Trial: 30911906
Drug: SHP465 mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHP465 mixed amphetamine salts (50 mg) with high-fat meal consumption 30 min before administration
Trial: 30911906
Drug: SHP465 mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHP465 mixed amphetamine salts (50 mg) sprinkled on applesauce
Trial: 30911906
Drug: SHP465 mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHP465 mixed amphetamine salts (50 mg) fasting (reference treatment)
Trial: 26925901
Drug: Blind corticosteroid
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind corticosteroid injection
Trial: 22646219
Drug: Desvenlafaxine 150
RxNorm normalized name: Desvenlafaxine
DrugBank: Desvenlafaxine (DB06700)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 150 mg/day
Trial: 20827547
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg orally once weekly
Trial: 9655733
Drug: High-dose prednisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose prednisone (60 mg/d for 1 month, tapered to 40 mg/d for the second month, then 40 mg every other day during the third month)
Trial: 9655733
Drug: Colchicine (0.6-1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (0.6-1.2 mg/d, as tolerated)
Trial: 2665493
Drug: 100 IU
RxNorm normalized name: Vitamin E 100 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 IU oxytocin administered into the umbilical veins
Trial: 870096
Drug: Marijuana cigarette
RxNorm normalized name: Picea mariana resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana cigarette (18 mg of delta‐9‐THC)
Trial: 870096
Drug: Placebo marijuana
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo marijuana cigarette (0.05 mg of delta‐9‐THC)
Trial: 11375826
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of propofol and small-dose ketamine (propofol 33 +/- 13 microg x kg(‐1) x min(‐1) and ketamine 3.7 +/- 1.5 microg x kg(‐1) x min(‐1))
Trial: 11375826
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of propofol and small-dose ketamine
Trial: 31500605
Drug: Stereotactic body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body radiotherapy (SBRT) + Androgen deprivation therapy (ADT)
Trial: 29490289
Drug: DHEA co-administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA co-administration
Trial: 17585117
Drug: Inhaled human
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled human [rDNA Origin] insulin
Trial: 15172365
Drug: CMC‐001 (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMC‐001 (0.8 g MnCl2)
Trial: 15172365
Drug: CMC‐001 (1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMC‐001 (1.6 g MnCl2)
Trial: 9655270
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g cefazolin intravenously every 8 hours
Trial: 7815722
Drug: Drip Infusion
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drip Infusion Cholecystography (DIC)
Trial: 30734629
Drug: Fentanyl-soaked Merocel®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl-soaked Merocel® packing (50 mcg)
Trial: 22813235
Drug: BRV 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BRV 150 mg/day
Trial: 21950702
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of Avastin
Trial: 21950702
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg Macugen
Trial: 21950702
Drug: Sequential treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential treatment (1 mg Avastin followed by 0.3 mg Macugen)
Trial: 10600092
Drug: rhIGF‐1 0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIGF‐1 0.01 mg/kg/hour and daily subcutaneous doses of rhGH 0.05 mg/kg/day
Trial: 7864425
Drug: esmolol, 1.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: esmolol, 1.3 mg/kg
Trial: 7864425
Drug: esmolol, 4.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: esmolol, 4.4 mg/kg
Trial: 7864425
Drug: labetalol, 0.13
FDA approved: no
EMA approved: no
PMDA approved: no
Description: labetalol, 0.13 mg/kg
Trial: 7864425
Drug: labetalol, 0.44
FDA approved: no
EMA approved: no
PMDA approved: no
Description: labetalol, 0.44 mg/kg
Trial: 2167806
Drug: Intralipid (10%)
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid (10%) and heparin (Lipid)
Trial: 6796270
Drug: Chlordesmethyldiazepam 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlordesmethyldiazepam 2 mg (CDDZ2)
Trial: 6796270
Drug: Chlordesmethyldiazepam 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlordesmethyldiazepam 1 mg (CDDZ1)
Trial: 24692816
Drug: Candesartan (8-12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (8-12 mg/d)
Trial: 16793604
Drug: Ketamine (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.25 mg/kg bolus followed by 0.5 mg.kg(‐1).h(‐1) infusion)
Trial: 12658084
Drug: Topical azelastine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical azelastine 0.02%
Trial: 12658084
Drug: Topical mitomycin
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical mitomycin C (0.2 mg/10 mL)
Trial: 9143790
Drug: Follow-up after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up after withdrawal from therapy
Trial: 29265884
Drug: Xbox Kinect
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xbox Kinect exergames played twice weekly for 8 weeks
Trial: 18190664
Drug: Opioid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid treatment exposure longer than 7 days
Trial: 18190664
Drug: Older participants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older participants randomized to buprenorphine treatment
Trial: 15864409
Drug: Electrolytic iron
RxNorm normalized name: electrolytic iron
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrolytic iron with 50 mg ascorbic acid (AA)
Trial: 9337181
Drug: gemfibrozil 1200
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: gemfibrozil 1200 mg/d
Trial: 2566048
Drug: Oral cyclosporin
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclosporin 10 mg/kg per day
Trial: 2566048
Drug: Colchicine 1
RxNorm normalized name: colchicine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine 1 mg orally per day
Trial: 794686
Drug: Tibezonium iodide
RxNorm normalized name: tibezonium iodide
DrugBank: Tibezonium iodide (DB13702)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibezonium iodide tablets
Trial: 28651370
Drug: Metformin administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin administered 850 mg twice a day
Trial: 20079208
Drug: HD‐DXM +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD‐DXM + RM group (40 mg/d of dexamethasone in a 4‐day pulse every 14 days for 3 cycles + 0.035 mg x kg(‐1) x d(‐1) for maintenance)
Trial: 20079208
Drug: HD‐DXM +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD‐DXM + SM group (40 mg/d of dexamethasone in a 4‐day pulse every 14 days for 3 cycles + 0.035 mg x kg(‐1) x d(‐1) only when platelet count < 20 x 10(9)/L)
Trial: 20079208
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine dosage of prednisone)
Trial: 15080375
Drug: 1 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml/kg of alcohol for 7 days
Trial: 55895
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (400 mg daily) for 1 week before and 1 week after 5 mCi therapy dose of 131I
Trial: 55895
Drug: 5 mCi
RxNorm normalized name: iobenguane I-131 15 MCI/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mCi of 131I without lithium therapy
Trial: 25664999
Drug: Multi-nutrient supplement
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-nutrient supplement (550 mg DHA, 550 mg EPA, 10 µg vitamin D3 and 8 g whey protein)
Trial: 17710152
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of HBV vaccine
Trial: 15567983
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei supplementation (750 mg daily containing 16 billion bacteria)
Trial: 15567983
Drug: Standard quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard quadruple therapy without Lactobacillus casei supplementation
Trial: 28351393
Drug: Honey supplementation
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey supplementation (20 g/day for 12 weeks)
Trial: 24365449
Drug: Rifaximin (550
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin (550 mg, twice daily)
Trial: 22034767
Drug: Spinal manipulative
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulative treatment
Trial: 22034767
Drug: Other advocated
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other advocated therapies
Trial: 16869815
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) 20 mg
Trial: 16869815
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) 40 mg
Trial: 16869815
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) multiple doses
Trial: 9452157
Drug: Nitrate therapy
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate therapy (intravenous infusion or orally)
Trial: 25136050
Drug: HPV4 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV4 vaccine
Trial: 19821184
Drug: All patients
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All patients seeking treatment (n=416)
Trial: 17209220
Drug: Vitamin and
RxNorm normalized name: Vitamin and Mineral Supplement
DrugBank: alpha-Tocopherol acetate (DB14003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin and multivitamin-mineral supplements
Trial: 15902439
Drug: p-[(123)I]iodo-L-phenylalanine (IPA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: p-[(123)I]iodo-L-phenylalanine (IPA) SPECT
Trial: 12054161
Drug: 150 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg/day of pamidronate
Trial: 3516296
Drug: Terodiline 25
RxNorm normalized name: terodiline 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terodiline 25 mg bid
Trial: 25472936
Drug: Heparin-bonded covered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded covered stents (VIABAHN® Endoprosthesis)
Trial: 18450596
Drug: Omega-3 LCPUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 LCPUFA (350 mg DHA and 650 mg EPA)
Trial: 14594184
Drug: Guided to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided to self-hypnotic relaxation
Trial: 10949784
Drug: Meta-analysis of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meta-analysis of randomized, controlled trials of cancer therapy
Trial: 21733143
Drug: Dietary advice
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary advice plus supplement
Trial: 12757558
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg/d for 4 weeks and 10 mg/d per clinician's judgment thereafter)
Trial: 7955807
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg dihydroergotamine and 300 mg troxerutin three times a day